Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Multi-Center, Open-Label, Single-Arm Extension Clinical Trial to Assess the Extended Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

Next Previous
Search
Trial Profile

A Phase 3, Multi-Center, Open-Label, Single-Arm Extension Clinical Trial to Assess the Extended Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects Who Completed Trial NVU-003 (Kalahari Study)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 26 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perfluorohexyloctane (Primary)
  • Indications Dry eyes; Meibomian gland dysfunction
  • Focus Adverse reactions
  • Acronyms Kalahari Study
  • Sponsors Bausch Health Companies; Novaliq

    • Most Recent Events

    • 26 Aug 2024 Results assessing long-term safety and efficacy of perfluorohexyloctane ophthalmic solution for the treatment of patients with dry eye disease published in the Cornea
    • 08 Jun 2023 According to a Bausch & Lomb media release, data from this study will be presented during the American Optometric Association (AOA) Optometrys Meeting e-posters Virtual Event,
    • 20 Apr 2023 According to a Bausch and Lomb Corporation media release, company will present 12-months results from this trial as scientific poster presentations during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, which will take place in New Orleans from April 23-27, 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top